Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-210.94M
↓ 108% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-101.57M
Historical baseline
PeriodValueYoY Change
2025$-210.94M-33.7%
2024$-157.78M-47.1%
2023$-107.29M-3.4%
2022$-103.73M-70.3%
2021$-60.91M-50.7%
2020$-40.40M+13.0%
2019$-46.41M+38.3%
2018$-75.23M+24.7%
2017$-99.93M+11.6%
2016$-113.04M-